Status:
WITHDRAWN
Bupivacaine Epiphora Trial
Lead Sponsor:
McMaster University
Conditions:
Epiphora
Ptosis
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The objective of this study is to investigate quantitative improvement in excessive tearing after administration of Bupivacaine, a local anesthetic, into the affected eyelids.
Eligibility Criteria
Inclusion
- Patients age 18 and above, patients with unilateral or bilateral excessive tearing.
Exclusion
- Pregnant females, vulnerable populations, patients with severe hepatic disease, or patients using monoamine oxidase inhibitors or tricyclic antidepressants, which are contraindicated with bupivacaine and norepinephrine combinations.
Key Trial Info
Start Date :
April 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 23 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03266081
Start Date
April 1 2015
End Date
August 23 2022
Last Update
August 25 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Icahn School of Medicine at Mount Sinai
New York, New York, United States, 10029